ExThera Medical Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 6

ExThera Medical General Information

Description

Developer of extracorporeal blood filtration devices designed to offer treatment of bloodstream infections. The company's medical devices include a single-use blood filter capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins, and other harmful substances from whole blood, enabling clinics and healthcare organizations to address unmet clinical needs of pathogen reduction in blood banking.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 757 Arnold Drive
  • Suite B
  • Martinez, CA 94553
  • United States
+1 (925)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 757 Arnold Drive
  • Suite B
  • Martinez, CA 94553
  • United States
+1 (925)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExThera Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 31-Jul-2023 $5M Completed Generating Revenue
5. Later Stage VC (Series B3) 10-Sep-2021 Completed Generating Revenue
4. Later Stage VC (Series B1) 17-Mar-2021 Completed Generating Revenue
3. Later Stage VC (Series B) 11-May-2016 Completed Generating Revenue
2. Later Stage VC (Series A) 11-May-2016 $12M $12M Completed Generating Revenue
1. Joint Venture 01-Jan-2007 Completed Startup
To view ExThera Medical’s complete valuation and funding history, request access »

ExThera Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3
Series B-2
Series B-1
Series B 9,491,945 $0.001000 $0.15 $1.82 $1.82 1x $1.82 13.74%
Series A 12,008,982 $0.001000 $0.08 $1 $1 1x $1 17.38%
To view ExThera Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ExThera Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of extracorporeal blood filtration devices designed to offer treatment of bloodstream infections. The company'
Surgical Devices
Martinez, CA
34 As of 2026

Lakewood, CO
 

Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ExThera Medical Competitors (7)

One of ExThera Medical’s 7 competitors is TerumoBCT, a Formerly PE-Backed company based in Lakewood, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TerumoBCT Formerly PE-Backed Lakewood, CO
Hamilton Medical Corporation Switzerland
Macopharma Corporation Tourcoing, France
Boston Scientific Corporation Marlborough, MA
Spine Wave Venture Capital-Backed Shelton, CT
You’re viewing 5 of 7 competitors. Get the full list »

ExThera Medical Patents

ExThera Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026231576-A1 Methods for increasing appetite Pending 28-Apr-2025
WO-2026035723-A1 Methods for concentrating blood components Pending 06-Aug-2024
EP-4820080-A1 Treatment for disease modification Pending 05-Dec-2023
WO-2025122575-A1 Treatment for disease modification Inactive 05-Dec-2023
EP-4815966-A1 Fluidized bed extracorporeal treatment device Pending 29-Nov-2023 A61K31/727
To view ExThera Medical’s complete patent history, request access »

ExThera Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExThera Medical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cycad Group Venture Capital Minority
Fraser Finance Growth/Expansion Minority
IRA Capital Real Estate Minority
NaHCO3 Impact Investing Minority
Emergence Venture Partners Venture Capital Majority
You’re viewing 5 of 6 investors. Get the full list »

ExThera Medical FAQs

  • When was ExThera Medical founded?

    ExThera Medical was founded in 2007.

  • Where is ExThera Medical headquartered?

    ExThera Medical is headquartered in Martinez, CA.

  • What is the size of ExThera Medical?

    ExThera Medical has 34 total employees.

  • What industry is ExThera Medical in?

    ExThera Medical’s primary industry is Surgical Devices.

  • Is ExThera Medical a private or public company?

    ExThera Medical is a Private company.

  • What is ExThera Medical’s current revenue?

    The current revenue for ExThera Medical is .

  • How much funding has ExThera Medical raised over time?

    ExThera Medical has raised $59.6M.

  • Who are ExThera Medical’s investors?

    Cycad Group, Fraser Finance, IRA Capital, NaHCO3, and Emergence Venture Partners are 5 of 6 investors who have invested in ExThera Medical.

  • Who are ExThera Medical’s competitors?

    TerumoBCT, Hamilton Medical, Macopharma, Boston Scientific, and Spine Wave are some of the 7 competitors of ExThera Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process